Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE MRIBAH : revenue, balance sheet and financial ratios

PHARMACIE MRIBAH is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75014), this company of category PME shows in 2022 a net income positive of 212 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE MRIBAH (SIREN 842749590)
Indicator 2022 2021
Revenue N/C N/C
Net income 211 884 € 218 915 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2022, PHARMACIE MRIBAH generates positive net income of 212 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2022: 219 k€ -> 212 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

211 884 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 456%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

455.564%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

16.403%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

50.3%

Solvency indicators evolution
PHARMACIE MRIBAH

Sector positioning

Debt ratio
455.56 2022
2021
2022
Q1: 24.51
Med: 74.73
Q3: 182.48
Average

In 2022, the debt ratio of PHARMACIE MRIBAH (455.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
16.4% 2022
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.62%
Average

In 2022, the financial autonomy of PHARMACIE MRIBAH (16.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 356.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

356.393

Liquidity indicators evolution
PHARMACIE MRIBAH

Sector positioning

Liquidity ratio
356.39 2022
2021
2022
Q1: 145.16
Med: 199.46
Q3: 274.98
Excellent

In 2022, the liquidity ratio of PHARMACIE MRIBAH (356.39) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE MRIBAH in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of PHARMACIE MRIBAH is estimated at 2 493 134 € (range 1 675 882€ - 3 739 239€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
1675k€ 2493k€ 3739k€
2 493 134 € Range: 1 675 882€ - 3 739 239€
NAF 5 année 2022

Valuation method used

Net Income Multiple
211 884 € × 11.8x = 2 493 135 €
Range: 1 675 882€ - 3 739 239€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE MRIBAH with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE MRIBAH

What is the revenue of PHARMACIE MRIBAH ?

The revenue of PHARMACIE MRIBAH is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE MRIBAH profitable?

Yes, PHARMACIE MRIBAH generated a net profit of 212 k€ in 2022.

Where is the headquarters of PHARMACIE MRIBAH ?

The headquarters of PHARMACIE MRIBAH is located in PARIS (75014), in the department Paris.

Where to find the tax return of PHARMACIE MRIBAH ?

The tax return of PHARMACIE MRIBAH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE MRIBAH operate?

PHARMACIE MRIBAH operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.